Aphria Inc  

(Public, CVE:APH)   Watch this stock  
Find more results for APH
-0.02 (-1.44%)
May 31 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.37 - 1.40
52 week 0.79 - 1.80
Open 1.39
Vol / Avg. 134,793.00/361,340.00
Mkt cap 94.40M
P/E     -
Div/yield     -
EPS -0.02
Shares 68.41M
Beta     -
Inst. own     -
Apr 21, 2016
Q3 2016 Aphria Inc Earnings Release

Key stats and ratios

Q1 (Feb '16) 2015
Net profit margin 0.14% -1186.63%
Operating margin -3.13% -615.78%
EBITD margin - -727.64%
Return on average assets 0.07% -90.40%
Return on average equity 0.07% -96.94%
CDP Score - -


269 Erie St S, PO Box 20009

Website links


Aphria, Inc. is a Canada-based company, which is engaged in greenhouse growing business. The Company is a medical marijuana producer. It provides medical marijuana to help reduce muscle spasms, appetite, or symptoms of anxiety and depression. It provides medical marijuana for end-of-life care or a specific medical condition, including multiple sclerosis, spinal cord injury, spinal cord disease, severe pain, cachexia, anorexia, weight loss, cancer, human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS), arthritis and seizures from epilepsy. In addition, the Company provides medical support services through its wholly owned subsidiary Cannway Pharmaceuticals Inc.